Say Goodbye to False Lashes: Natural Ways to Grow Longer Eyelashes - Jordan News
Source: Lebanon 24
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Al Bawaba
an hour ago
- Al Bawaba
"The war didn't kill him, trauma did": Israeli soldier takes his own life
ALBAWABA - An Israeli soldier killed himself after months of trauma on the front lines in Gaza and Lebanon. This shows that the Israeli military's mental health problem is getting worse. The soldier had been going through a lot of mental pain since losing two close friends in the attacks on October 7, 2023, according to the Israeli news site Walla. His family said that the soldier was greatly affected by the horrible things that happened in war, and that he often complained about the smell of dead bodies and the horrible things he saw while getting the bodies of soldiers who had died. The Israeli army allegedly won't give him a military funeral, even though he served. This latest suicide is the latest in a string of deaths by suicide by Israeli troops. Israeli news outlets state that at least 43 soldiers have killed themselves since the war started. Most of them did so because they were traumatized by fighting for so long in Gaza and Lebanon. Haaretz said that 35 of these cases had already happened by the end of 2024, and seven more were proven in the beginning of 2025. The army won't give out full numbers, and soldiers who killed themselves are often buried without military honors. انتحار جندي إسرائيلي بسبب معاناته من مشاكل نفسية نتيجة خدمته العسكرية المتواصلة في غزة ولبنان حسب عائلته، حيث قام بإشعال نفسه في مركبته بالأحراش المحيطة بمدينة صفد. حسب أقوال والدته كان يعاني من نوبات غضب وقام بتحطيم شقته في احدى تلك النوبات. تحطيم الشقق والبيوت يتعلمونها أثناء… July 6, 2025 Due to a lack of soldiers, military sources also said that the Israel Defense Forces (IDF) has been recruiting reservists with known mental illnesses, including some who are currently getting treatment. Since the war started, more than 9,000 troops have asked for help with their mental health. "We're fighting with what we have," a top officer said, admitting that the army has to use mentally ill soldiers. According to an earlier report from the Israeli Ministry of Defense, 43% of soldiers who are hurt and in rehabilitation centers have PTSD. It is thought that by 2030, up to 100,000 people, mostly soldiers, will need long-term mental health care because of the war.
Jordan News
a day ago
- Jordan News
Say Goodbye to False Lashes: Natural Ways to Grow Longer Eyelashes - Jordan News
Say Goodbye to False Lashes: Natural Ways to Grow Longer Eyelashes Long, thick eyelashes are considered a symbol of beauty and allure, which is why many women strive to achieve healthy, naturally long lashes. But is it really possible to grow them? The answer is yes—provided you commit to consistent care and use the right methods. اضافة اعلان Causes of Weak or Falling Eyelashes: Frequent use of heavy makeup without proper cleansing Rubbing the eyes harshly or removing mascara aggressively Poor nutrition or vitamin deficiencies Aging or genetic factors Using low-quality cosmetic products Natural Methods to Grow Longer Eyelashes: 1. Castor Oil One of the most popular oils for strengthening and lengthening lashes. Apply a small amount using a clean mascara brush before bedtime. 2. Coconut Oil or Olive Oil Both are rich in fatty acids and nourishing vitamins. Apply in the same way as castor oil for softening and strengthening lashes. 3. Aloe Vera (Aloe Gel) Helps hydrate and strengthen the lashes. Apply using a clean brush and leave it on overnight. 4. Proper Nutrition Eating foods rich in vitamins like Vitamin E, A, B7 (Biotin), and Zinc supports healthy hair and eyelash growth. 5. Adequate Water and Sleep Dehydration and lack of sleep negatively affect the health of your skin and hair, including your lashes. Source: Lebanon 24
Al Bawaba
2 days ago
- Al Bawaba
A Landmark Global Trial Led from Lebanon: Mitapivat in NTDT Published in The Lancet
In a major advancement for global thalassemia care, the results of a landmark global phase 3 clinical trial of mitapivat in non-transfusion-dependent thalassemia (NTDT) led by the American University of Beirut (AUB) and the Chronic Care Center, the thalassemia center in Lebanon, have been published in The Lancet, one of the world's leading medical study, titled 'Phase 3 trial of mitapivat in non-transfusion-dependent alpha- or beta-thalassemia,' led by Dr. Ali Taher, professor of medicine at the Division of Hematology and Oncology, director of the Naef K. Basile Cancer Institute, and consultant at the Chronic Care Center served as both global principal investigator and first and corresponding author. It is the first to demonstrate the efficacy of an oral, disease-modifying therapy for both beta and alpha forms of NTDT, positioning mitapivat as a potential game changer in the treatment of this lifelong blood disorder.'This publication is more than a scientific milestone,' said Dr. Taher. 'It's proof that Lebanon, even in its hardest times, can lead groundbreaking medical advances that change global standards of care. I'm proud this trial was conceived, led, and delivered from AUB and the Chronic Care Center.'NTDT is a lifelong inherited blood disorder that results in chronic anemia. Patients with NTDT do not require blood transfusions, but still suffer from chronic anemia and associated complications, including iron overload and reduced quality of life. Until now, therapeutic options for these patients have been is currently under review by the United States Food and Drug Administration (FDA) for potential marketing authorization. If approved, it would become the first FDA-authorized oral disease-modifying treatment for NTDT, offering a transformative option for thousands of patients phase 3 trial met all of its primary and secondary endpoints, demonstrating statistically and clinically significant improvements in hemoglobin levels, alongside favorable safety and tolerability work represents the culmination of over a decade of research, beginning with redefining the disease and understanding the morbidity and mortality risks of untreated anemia and iron overload. It builds on prior global efforts led from AUB that resulted in the approval of key therapies, including iron chelation through the THALASSA trial and luspatercept through the BEYOND trial. Both studies were led by Dr. Ali Taher, whose vision and leadership have been instrumental in transforming the global approach to thalassemia care. Widely recognized as one of the foremost experts in the field, Dr. Taher has played a central role in advancing treatment standards and improving outcomes for patients worldwide. His long-standing commitment to thalassemia research has not only shaped the current therapeutic landscape, but has also positioned Lebanon and AUB at the forefront of international medical innovation. This achievement serves as a powerful affirmation of AUB's role as a beacon of academic and clinical excellence, firmly committed to advancing health through research, education, and patient-centered innovation. It also reflects the resilience and determination of Lebanon's medical and scientific communities to contribute meaningfully to global health, despite the formidable challenges faced at home.
